NEOS Investment Management’s McCormick & Company Non-Voting MKC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
41,197
+4,902
+14% +$240K 0.01% 508
2026
Q1
$1.83M Buy
36,295
+4,718
+15% +$301K 0.01% 498
2025
Q4
$2.15M Buy
31,577
+5,727
+22% +$380K 0.01% 465
2025
Q3
$1.73M Buy
25,850
+8,589
+50% +$602K 0.01% 458
2025
Q2
$1.31M Buy
17,261
+3,572
+26% +$268K 0.02% 444
2025
Q1
$1.13M Buy
13,689
+2,506
+22% +$196K 0.02% 422
2024
Q4
$853K Buy
11,183
+2,483
+29% +$195K 0.02% 433
2024
Q3
$716K Buy
8,700
+1,624
+23% +$127K 0.02% 437
2024
Q2
$502K Buy
7,076
+1,992
+39% +$145K 0.02% 453
2024
Q1
$391K Buy
5,084
+1,817
+56% +$123K 0.02% 444
2023
Q4
$224K Buy
+3,267
New +$214K 0.02% 474

Other funds holding MKC

NEOS Investment Management's MKC Position: Q2 2026 in Review

NEOS Investment Management increased its McCormick & Company Non-Voting (MKC) stake by 14% in Q2 2026, buying an estimated $240K and bringing the position to 41,197 shares worth $2.08M. The position accounts for 0.01% of the portfolio, ranked #508.

NEOS Investment Management first reported a position in MKC in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.15M in Q4 2025. 953 funds tracked by Wall St. Rank hold MKC as of Q2 2026.

  • NEOS Investment Management held 41,197 shares of McCormick & Company Non-Voting worth $2.08M as of Q2 2026.
  • NEOS Investment Management bought 4,902 McCormick & Company Non-Voting shares in Q2 2026, an estimated $240K.
  • McCormick & Company Non-Voting made up 0.01% of NEOS Investment Management's portfolio in Q2 2026, its #508 holding.
  • NEOS Investment Management first reported a position in McCormick & Company Non-Voting in Q4 2023 and has held it in 11 quarters since.
  • NEOS Investment Management's McCormick & Company Non-Voting position peaked at $2.15M in Q4 2025.
  • 953 funds tracked by Wall St. Rank held McCormick & Company Non-Voting as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.